José Antônio Marin‐Neto

Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

Carlos A. Morillo, José Antônio Marin‐Neto, Álvaro Avezum et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.

Vasken Dilsizian, James A. Arrighi, Jean G. Diodati et al. · Circulation · 1994 · 274 citations · Full text

Medicine, Cardiology, Nuclear Medicine +17

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)

José Antônio Marin‐Neto, Anis Rassi, Carlos A. Morillo et al. · American Heart Journal · 2008 · 210 citations

Medicine, Cardiology, Pharmacology +12

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Anis Rassi, Anis Rassi, José Antônio Marin‐Neto · Memórias do Instituto Oswaldo Cruz · 2009 · 196 citations · Full text

Veterinary Medicine, Cardiology, Infectious Diseases +17